| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |